Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.97 USD | +0.53% | +0.90% | -4.19% |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 48.61 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.19% | 13.35B | A | ||
+6.23% | 57.29B | A- | ||
-6.12% | 18.92B | A- | ||
+2.22% | 7.74B | B | ||
-15.50% | 5.68B | B- | ||
+11.57% | 3.37B | C- | ||
+0.56% | 3.32B | C+ | ||
-1.49% | 3.21B | B+ | ||
+15.88% | 2.81B | C- | ||
-8.96% | 2.57B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOC Stock
- Ratings Healthpeak Properties, Inc.